{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:03:46Z","timestamp":1781975026859,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Endometrial sampling for the surveillance of women with Lynch syndrome is an invasive and painful procedure. The aim of this study was to evaluate the feasibility of a less invasive procedure of collecting vital cells by vaginal tampons.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a prospective feasibility study of women scheduled to undergo annual gynecological surveillance, including endometrial sampling. We included consecutive asymptomatic women with Lynch syndrome or first-degree relatives and asked them to insert a vaginal tampon 2\u20134\u2009h before attending their outpatient appointment. Feasibility was evaluated by the following metrics: patient acceptance, pain intensity of each procedure (assessed by visual analog scale; range 0\u201310), and the presence of vital cells obtained by tampon-based or endometrial sampling methods. Two pathologists independently evaluated all samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 25 of 32 approached women completed the tampon-based procedure, with 23 of these subsequently undergoing invasive endometrial sampling. The median visual analog scale scores for tampon use and invasive endometrial sampling were 0 (range, 0\u201310) and 5.5 (range, 1\u201310) (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001). None of the tampon samples analyzed by cytology showed endometrial cells, but they did contain vital squamous cells and granulocytes. By contrast, 18 (78%) of the invasive endometrial samples contained enough endometrial tissue for analysis. No endometrial abnormalities were found by endometrial sampling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Tampon-based endometrial surveillance was a well-accepted and non-painful procedure, and although tampons contained vital cells, they did not provide endometrial cells. However, this study was limited to asymptomatic women with Lynch syndrome (no endometrial pathology), indicating that research is needed to evaluate whether the tampon method has any utility for endometrial surveillance in women with Lynch syndrome.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12905-020-00920-y","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T15:02:39Z","timestamp":1584457359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome"],"prefix":"10.1186","volume":"20","author":[{"given":"Jorien M.","family":"Woolderink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida H.","family":"De Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettien M.","family":"van Hemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Geuken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"2","key":"920_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135(2):419\u201328.","journal-title":"Gastroenterology"},{"issue":"2","key":"920_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","volume":"75","author":"E Barrow","year":"2009","unstructured":"Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet. 2009;75(2):141\u20139.","journal-title":"Clin Genet"},{"key":"920_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/djp473","volume":"102","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193\u2013201.","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"920_CR4","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305(22):2304\u201310.","journal-title":"JAMA."},{"issue":"3","key":"920_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/humu.22262","volume":"34","author":"JG Dowty","year":"2013","unstructured":"Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34(3):490\u20137.","journal-title":"Hum Mutat"},{"issue":"12","key":"920_CR6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","volume":"3","author":"NAJ Ryan","year":"2017","unstructured":"Ryan NAJ, Morris J, Green K, Lalloo F, Woodward ER, Hill J, et al. Association of Mismatch Repair Mutation with age at cancer onset in Lynch Syndrome: implications for stratified surveillance strategies. JAMA Oncol. 2017;3(12):1702\u20136.","journal-title":"JAMA Oncol"},{"key":"920_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2019","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT, Ten Broeke SW, Plazzer JP, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective Lynch syndrome database. Genet Med. 2019;22:15\u201325.","journal-title":"Genet Med"},{"key":"920_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ijc.22446","volume":"120","author":"L Renkonen-Sinisalo","year":"2006","unstructured":"Renkonen-Sinisalo L, Butzow R, Leminen A, Lehtovirta P, Mecklin JP, Jarvinen HJ. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer. 2006;120:821\u20134.","journal-title":"Int J Cancer"},{"issue":"1","key":"920_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","volume":"91","author":"FE Rijcken","year":"2003","unstructured":"Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol. 2003;91(1):74\u201380.","journal-title":"Gynecol Oncol"},{"key":"920_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10689-009-9252-x","volume":"8","author":"LHM Gerritzen","year":"2009","unstructured":"Gerritzen LHM, Hoogerbrugge N, Oei AL, Nagengast FM, Van Ham MA, Massuger LF, de Hullu JA. Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome. Familial Cancer. 2009;8:391\u20137.","journal-title":"Familial Cancer"},{"issue":"6","key":"920_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00404-012-2492-2","volume":"286","author":"R Manchandra","year":"2012","unstructured":"Manchandra R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, et al. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC\/Lynch syndrome (LS). Arch Gynecol Obstet. 2012;286(6):1555\u201362.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"920_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ygyno.2013.05.032","volume":"131","author":"JM Helder-Woolderink","year":"2013","unstructured":"Helder-Woolderink JM, De Bock GH, Sijmons RH, Hollema H, Mourits MJ. The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome. Gynecol Oncol. 2013;131(2):304\u20138.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"920_CR13","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","volume":"21","author":"EJ Crosbie","year":"2019","unstructured":"Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, et al. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med. 2019;21(10):2390\u2013400.","journal-title":"Genet Med"},{"key":"920_CR14","unstructured":"http:\/\/www.oncoline.nl\/hereditary colorectal cancer [accessed at 15 June 2018]."},{"issue":"4","key":"920_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10689-009-9259-3","volume":"8","author":"K Elmasry","year":"2009","unstructured":"Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K. Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Familial Cancer. 2009;8(4):431\u20139.","journal-title":"Familial Cancer"},{"issue":"2","key":"920_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10689-016-9937-x","volume":"16","author":"J Helder-Woolderink","year":"2017","unstructured":"Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M. Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Familial Cancer. 2017;16(2):205\u201310.","journal-title":"Familial Cancer"},{"issue":"1","key":"920_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JOP.2010.000038","volume":"7","author":"M Huang","year":"2011","unstructured":"Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, et al. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract. 2011;7(1):43\u20137.","journal-title":"J Oncol Pract"},{"issue":"1","key":"920_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ygyno.2014.08.017","volume":"135","author":"DR Nebgen","year":"2014","unstructured":"Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM. Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol. 2014;135(1):85\u20139.","journal-title":"Gynecol Oncol"},{"key":"920_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/1097-0142(195411)7:6<1182::AID-CNCR2820070609>3.0.CO;2-F","volume":"7","author":"A Brunschwig","year":"1954","unstructured":"Brunschwig A. A method for mass screening for cytological detection of carcinoma of the cervix uteri. Cancer. 1954;7:1182\u20134.","journal-title":"Cancer."},{"key":"920_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/1097-0142(195411)7:6<1185::AID-CNCR2820070610>3.0.CO;2-W","volume":"7","author":"GN Papanicolaou","year":"1954","unstructured":"Papanicolaou GN. Cytological evaluation of smears prepared by the tampon method for the detection of carcinoma of the uterine cervix. Cancer. 1954;7:1185\u201390.","journal-title":"Cancer."},{"key":"920_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0142(195701\/02)10:1<120::AID-CNCR2820100117>3.0.CO;2-H","volume":"10","author":"A Brunschwig","year":"1957","unstructured":"Brunschwig A. Detection of endometrial adenocarcinoma by tampon smear method. Cancer. 1957;10:120\u20133.","journal-title":"Cancer."},{"key":"920_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/1097-0142(195703\/04)10:2<332::AID-CNCR2820100213>3.0.CO;2-2","volume":"10","author":"GM Bader","year":"1957","unstructured":"Bader GM, Simon TR, Koss LG, Day E. A study of the detection-tampon method as a screening device for uterine cancer. Cancer. 1957;10:332\u20137.","journal-title":"Cancer."},{"issue":"5","key":"920_CR23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1055-9965.882.13.5","volume":"13","author":"H Fiegl","year":"2004","unstructured":"Fiegl H, Gattringer C, Widschwendter A, Schneitter A, Ramoni A, Sarlay D, et al. Methylated DNA collected by tampons- a new tool to detect endometrial cancer. Cancer Epidemiol Biomark Prev. 2004;13(5):882\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"920_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/AOG.0000000000000484","volume":"124","author":"BK Erickson","year":"2014","unstructured":"Erickson BK, Kinde I, Dobbin ZC, Wang Y, Martin JY, Alvarez RD, et al. Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer. Obstet Gynecol. 2014;124(5):881\u20135.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"920_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ygyno.2015.01.552","volume":"137","author":"JN Bakkum-Gamez","year":"2015","unstructured":"Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, et al. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol Oncol. 2015;137(1):14\u201322.","journal-title":"Gynecol Oncol"},{"key":"920_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10689-007-9123-2","volume":"6","author":"F L\u00e9curu","year":"2007","unstructured":"L\u00e9curu F, Metzger U, Scarabin C, Le Fr\u00e8re Belda MA, Olschwang S, Puig PL. Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study. Familial Cancer. 2007;6:295\u20139.","journal-title":"Familial Cancer"},{"issue":"3","key":"920_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/AOG.0b013e31820ad45b","volume":"117","author":"CM Leclair","year":"2011","unstructured":"Leclair CM, Zia JK, Doom CM, Morgan TK, Edelman AB. Pain experienced using two different methods of endometrial biopsy: a randomized controlled trial. Obstet Gynecol. 2011;117(3):636\u201341.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"920_CR28","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/cncr.11157","volume":"97","author":"T Saito","year":"2003","unstructured":"Saito T, Nishimura M, Yamasaki H, Kudo R. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer. 2003;97(4):1002\u20139.","journal-title":"Cancer."},{"issue":"13","key":"920_CR29","first-page":"3663","volume":"62","author":"M Zysman","year":"2002","unstructured":"Zysman M, Saka A, Millar A, Knight J, Chapman W, Bapat B. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. Cancer Res. 2002;62(13):3663\u20136.","journal-title":"Cancer Res"},{"issue":"18","key":"920_CR30","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/sj.onc.1202178","volume":"17","author":"M Esteller","year":"1998","unstructured":"Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998;17(18):2413\u20137.","journal-title":"Oncogene."},{"issue":"3","key":"920_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1054\/bjoc.1999.0980","volume":"82","author":"H Tsuda","year":"2000","unstructured":"Tsuda H, Yamamoto K, Inoue T, Uchiyama I, Umesaki N. The role of p16-cyclin d\/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer. 2000;82(3):675\u201382.","journal-title":"Br J Cancer"},{"issue":"8","key":"920_CR32","first-page":"3262","volume":"61","author":"M Sasaki","year":"2001","unstructured":"Sasaki M, Kotcherguina L, Dharia A, Fujimoto S, Dahiya R. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer. Cancer Res. 2001;61(8):3262\u20136.","journal-title":"Cancer Res"},{"issue":"1","key":"920_CR33","first-page":"97","volume":"61","author":"M Sasaki","year":"2001","unstructured":"Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res. 2001;61(1):97\u2013102.","journal-title":"Cancer Res"},{"issue":"1","key":"920_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S","volume":"91","author":"HB Salvesen","year":"2001","unstructured":"Salvesen HB, MacDonald N, Ryan A, Jacobs IJ, Lynch ED, Akslen LA, Das S. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer. 2001;91(1):22\u20136.","journal-title":"Int J Cancer"},{"issue":"7","key":"920_CR35","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.3390\/ijms140715029","volume":"14","author":"Y Delpu","year":"2013","unstructured":"Delpu Y, Cordelier P, Cho WC, Torrisani J. DNA methylation and cancer diagnosis. Int J Mol Sci. 2013;14(7):15029\u201358.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"920_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/cncr.10478","volume":"96","author":"E Brogi","year":"2002","unstructured":"Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002;96(2):60\u20136.","journal-title":"Cancer."},{"issue":"2","key":"920_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/01.lgt.0000210130.01016.ad","volume":"10","author":"DL Greenspan","year":"2006","unstructured":"Greenspan DL, Cardillo M, Davey DD, Heller DS, Moriarty AT. Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis. 2006;10(2):111\u201322.","journal-title":"J Low Genit Tract Dis"},{"key":"920_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","volume":"11","author":"C Bewtra","year":"1992","unstructured":"Bewtra C, Watson P, Conway T, Read-Hippee C, Lynch HT. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol. 1992;11:180\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"920_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10689-008-9219-3","volume":"8","author":"EM Grindedal","year":"2009","unstructured":"Grindedal EM, Blanco I, Stormorken A, Maehle L, Clark N, Gonzalez S, et al. High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers. Familial Cancer. 2009;8:145\u201351.","journal-title":"Familial Cancer"},{"key":"920_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","volume":"36","author":"A Aysal","year":"2012","unstructured":"Aysal A, Karnezis A, Medhi I, Grenert JP, Zaloudek CJ, Rabban JT. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol. 2012;36:163\u201372.","journal-title":"Am J Surg Pathol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00920-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-020-00920-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00920-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T23:53:15Z","timestamp":1666137195000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-00920-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-00920-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee of the University Medical Center in Groningen approved the study in October 2016, METc 2016\/292. Written informed consent was obtained from all included patients in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}